Dexcom Launches the First Generative AI Platform in Glucose Biosensing
Press Release – December 17, 2024 – SAN DIEGO – DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to integrate GenAI into glucose biosensing technology.1 The new Dexcom GenAI platform will analyze individual health data patterns to reveal a direct association between lifestyle choices and glucose levels while providing … Continue reading Dexcom Launches the First Generative AI Platform in Glucose Biosensing